ArrowMark Colorado Holdings LLC Decreases Position in The Cooper Companies, Inc. (NASDAQ:COO)

ArrowMark Colorado Holdings LLC lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 2.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,144,633 shares of the medical device company's stock after selling 29,958 shares during the period. Cooper Companies makes up approximately 1.4% of ArrowMark Colorado Holdings LLC's holdings, making the stock its 20th biggest position. ArrowMark Colorado Holdings LLC owned approximately 0.57% of Cooper Companies worth $105,226,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Fulton Bank N.A. increased its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after acquiring an additional 109 shares in the last quarter. Covestor Ltd grew its position in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the last quarter. Torray Investment Partners LLC increased its stake in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. raised its holdings in shares of Cooper Companies by 7.4% in the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after buying an additional 133 shares during the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in shares of Cooper Companies by 15.6% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock valued at $93,000 after buying an additional 136 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

COO has been the subject of a number of research analyst reports. Piper Sandler restated an "overweight" rating and issued a $115.00 target price (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus reduced their price objective on Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Finally, BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Trading Down 1.2 %

COO stock traded down $1.00 during trading on Tuesday, reaching $80.57. 1,633,090 shares of the stock were exchanged, compared to its average volume of 1,437,764. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market capitalization of $16.11 billion, a price-to-earnings ratio of 41.32, a P/E/G ratio of 2.25 and a beta of 1.08. The business has a 50 day moving average price of $81.25 and a 200-day moving average price of $91.50. The Cooper Companies, Inc. has a 1 year low of $69.81 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. On average, research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.